🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase I, single-center, randomized, open-label, single-dose, thre...
Status
Completed
Location
Zhongshan Hositpal
Start Date
2021-03-02
Trial ID
NCT05507294
Treatments Being Tested
To explore the safety and efficacy of Glumetinib combined with Osimertinib ...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2019-11-18
Trial ID
NCT04338243
Treatments Being Tested
To evaluate the efficacy and safety of glumetinib combined with osimertinib...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-04-01
Trial ID
NCT06908772
Treatments Being Tested
This is an open-label, multicenter Phase Ib/II registration clinical study,...
Status
Terminated
Location
Guangdong Provincial People's Hospital
Start Date
2021-04-21
Trial ID
NCT04797702
Treatments Being Tested
This study evaluated the efficacy and safety of gumarontinib combined with ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-06-01
Trial ID
NCT06452433
Treatments Being Tested
The is a randomized, controlled, open-label Phase III clinical study to eva...
Status
Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2025-04-03
Trial ID
NCT06829459
Treatments Being Tested
The trial consists of Stage 1 (including dose escalation and dose expansion...
Status
Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2025-06-04
Trial ID
NCT06947291
Treatments Being Tested
Glumetinib combined withFruquintinib in the treatment of MET amplification ...
Status
Recruiting
Location
Huazhong University of Science and Technology
Start Date
2025-04-25
Trial ID
NCT06980532
Treatments Being Tested
This is a descriptive observational study in which data are collected in an...
Status
Recruiting
Location
Hunan Province Tumor Hospital
Start Date
2020-01-01
Trial ID
NCT06183762
Treatments Being Tested
This is a Phase 1a/1b multi-center and open label study to evaluate the saf...
Status
Completed
Location
Shanghai East hospital
Start Date
2017-12-16
Trial ID
NCT03457532
Treatments Being Tested